文献速递腹部技术与安全CT

光子计数探测器CT一站式多能量胰腺动态容积灌注成像:初步经验

One-Stop multienergy pancreatic dynamic volume perfusion imaging using photon-counting detector CT: Initial experience.
PubMed 文献 · Eur J Radiol · 2025-06-27

本研究前瞻性纳入65例组织学确诊的胰腺导管腺癌(PDAC)患者,采用光子计数探测器CT行术前胰腺动态容积灌注成像,评估图像质量与灌注参数。结果显示平均有效辐射剂量16.4±4.5 mSv,55 keV虚拟单能图像对病灶及邻近血管对比噪声比最高;PDAC病灶与正常胰腺实质间多个灌注参数差异显著,低分化PDAC的BF、BV、TTD、Tmax及BF、BV、FEP病灶/实质比值显著低于中高分化者。

要点

  • 55 keV虚拟单能图像在胰腺实质期和门静脉期对PDAC病灶显示主观评分最优,且病灶与邻近血管CNR最高。
  • PDAC病灶与正常胰腺实质间BF、BV、TTD、MTT、TTS、Tmax、FEP差异均有统计学意义。
  • 低分化PDAC的BF、BV、TTD、Tmax及BF、BV、FEP病灶/实质比值显著低于中高分化PDAC。

核心结论

  • 光子计数探测器CT一站式多能量胰腺动态容积灌注成像方案可在较低辐射剂量下实现高质量形态学成像和可靠的功能灌注评估,为PDAC分化及组织病理分级提供有价值的信息,可能对改善临床管理有潜在意义。

研究设计与样本

  • 前瞻性研究,2024年4月至2024年10月纳入65例疑似PDAC并最终组织学确诊的参与者,行术前胰腺动态容积灌注CT,采用光子计数探测器CT,从灌注数据集提取各期图像并以T3D重建55 keV和70 keV虚拟单能图像用于诊断判读,参考标准为组织病理学确诊。

关键影像表现/征象

  • 55 keV虚拟单能图像在胰腺实质期和门静脉期对病灶显示的主观评分最优,且PDAC病灶及邻近血管的CNR最高(均p<0.05)。
  • 所有单期图像均达到诊断质量标准(主观评分≥3分)。

诊断标准与关键数值

  • 图像质量主观评分≥3分判定为达到诊断质量标准。
  • PDAC病灶与正常胰腺实质间BF、BV、TTD、MTT、TTS、Tmax、FEP差异均有统计学意义(均p<0.05)。
  • 低分化PDAC较低分化程度者表现为BF、BV、TTD、Tmax值及BF、BV、FEP病灶/实质比值显著降低。

临床应用与阅片要点

  • 可参考本方案采用55 keV虚拟单能图像用于PDAC病灶显示及邻近血管评估。
  • 灌注参数BF、BV、TTD、Tmax及BF、BV、FEP病灶/实质比值可能有助于提示PDAC分化程度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This study reports initial experience with a modified one-stop, multienergy pancreatic VPCT protocol using PCCT, designed for comprehensive morphologic analysis and functional perfusion assessment of pancreatic ductal adenocarcinoma (PDAC).

MATERIALS AND METHODS: From April 2024 to October 2024, participants with suspected PDAC were prospectively enrolled and underwent preoperative pancreatic dynamic VPCT. Individual phase images were extracted from perfusion datasets using T3D, virtual monoenergetic images (VMIs) at 55 and 70 keV reconstruction for diagnostic interpretation. Diagnostic image quality was assessed both quantitatively and subjectively. Perfusion maps were generated for analysis. Perfusion parameters were compared between PDAC lesions and normal parenchyma, as well as among PDAC histopathological differentiation. Radiation doses were recorded.

RESULTS: A total of 65 participants (39 male; mean age, 66.2 ± 6.3 years) with histologically confirmed PDAC were included. The protocol achieved a mean effective radiation dose of 16.4 ± 4.5 mSv. All individual phase images met diagnostic quality standards (subjective scores ≥ 3). Among these, 55 keV VMIs demonstrated the highest CNR for PDAC lesions and adjacent vasculature, and superior subjective scores for lesion conspicuity in both pancreatic parenchymal and portal venous phases (all p < 0.05). Perfusion parameters, including blood flow (BF), blood volume (BV), time to drain (TTD), mean transit time, time to start, Tmax, and flow extraction product (FEP), differed significantly between PDAC lesions and normal parenchyma (all p < 0.05). Poorly differentiated PDAC lesions exhibited significantly lower BF, BV, TTD, and Tmax values and reduced lesion-to-parenchyma ratios of BF, BV, and FEP compared to moderately-to-well-differentiated PDAC lesions.

CONCLUSION: The one-stop, multienergy pancreatic VPCT protocol using PCCT enables high-quality morphologic imaging and reliable functional perfusion assessment at reduced radiation doses. It provides valuable insights into PDAC differentiation and histopathological grading, with potential implications for improved clinical management.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Yang Y, Zhu N, Lin H, et al. One-Stop multienergy pancreatic dynamic volume perfusion imaging using photon-counting detector CT: Initial experience. Eur J Radiol. 2025. PMID: 40609259. doi:10.1016/j.ejrad.2025.112268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。